News Articles

More than 1.6 million patients in the U.S. today have tricuspid regurgitation, which is a difficult-to-manage, age-related disease. In tricuspid regurgitation, the heart’s tricuspid valve does not close properly, causing blood to flow backward (leak) into the right upper heart chamber (atrium) when the right lower heart chamber (ventricle) contracts, reducing its efficiency. Patients with FTR may experience symptoms such as active pulsing in the neck veins, decreased urine output, fatigue/tiredness, general swelling, swelling of the abdomen or feet and ankles, and weakness.

Across the United States, the availability of donated hearts remains limited and tragically, many patients die waiting before a donor is found. According to the U.S. Department of Health and Human Services Organ Procurement and Transplantation Network, as of late September 2019, there were nearly 3,700 candidates on the waiting list for a heart transplant.